Examining Adolescent Assessment, Feedback, Incentive, and Exchange (AFIX) in North Carolina

Not Applicable

Completed

• Conditions: Adolescent Health Services; Immunization
• Interventions: Other: Assessment , Feedback, Incentives, and eXchange Program

• Registration Number: NCT01544764
• Lead Sponsor: University of North Carolina, Chapel Hill

Brief Summary

The North Carolina Immunization Branch will evaluate the use of the CDC program to improve adolescent vaccination practices (called Assessment, Feedback, Incentives, and eXchanges, or AFIX). This evaluation is the first of its kind in the nation and may have a profound impact on prevention.

AFIX has four major components: 1) Assessment of a provider's current immunization practices and vaccination levels, 2) Feedback of the assessment results and strategies to improve coverage levels, 3) Incentives to improve coverage levels, and 4) eXchange of information and resources necessary to facilitate improvement.

This program will evaluate the effectiveness of AFIX visits on affecting provider practices to increase adolescent (age 11-18) immunization. Visits include discussion of that practice's immunization rates and strategies for improving rates. The investigators will compare the changes, from baseline to 5 months, in immunization for practices receiving virtual visits (webinars), in-person visits, and no visits (control group). Thirty practices will be randomly assigned to each intervention type. The main outcomes of this study are practice-wide uptake rates of several adolescent vaccines (Tdap, HPV, and MCV4) as well as pre- and post-AFIX visit surveys focusing on recall tactics utilized by each practice. Data will be collected on practices with at least 200 adolescent patients (note: there is no patient-level data collected in this study).

Detailed Description

Not available

Study Timeline

• Study Start: 2011-04
• Study First Submitted: 2012-02-24
• Study First Submitted QC: 2012-02-29
• Study First Posted: 2012-03-06
• Primary Completion: 2012-12
• Study Completion: 2012-12
• Status Verified: 2013-12
• Last Update Submitted: 2013-12-16
• Last Update Posted: 2013-12-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 91

Inclusion Criteria

• Pediatric and/or family practices participating in the North Carolina Immunization Program
• A minimum of 200 active adolescent patients

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
AFIX In-Person Visit	Assessment , Feedback, Incentives, and eXchange Program	This arm includes 30 health centers in North Carolina with at least 200 adolescent (age 11-18) patients. These practices received an in-person AFIX visit from a North Carolina Immunization Branch employee. Intervention: Other: Assessment , Feedback, Incentives, and eXchange Program
AFIX Webinar Visit	Assessment , Feedback, Incentives, and eXchange Program	This arm includes 31 health centers in North Carolina with at least 200 adolescent (age 11-18) patients. These practices received a webinar during which a North Carolina Immunization Branch employee completed the components of an AFIX visit. Intervention: Other: Assessment , Feedback, Incentives, and eXchange Program

Primary Outcome Measures

Name	Time	Method
Change in Vaccination Rate: HPV vaccine initiation among 11-12 year olds	Baseline and 5 months follow-up	We will gather practice-specific rates of coverage for adolescents (age 11-12) for the first dose of human papillomavirus (HPV) vaccine at baseline and 5 months follow-up.

Secondary Outcome Measures

Name	Time	Method
Change in Vaccination Rate: HPV vaccine initiation among 13-18 year olds	Baseline and 5 months follow-up	We will gather practice-specific rates of coverage for adolescents (age 13-18) for the first dose of human papillomavirus (HPV) vaccine at baseline and 5 months follow-up.
Change in Vaccination Rate: Tdap vaccine among 11-12 year olds	Baseline and 5 months follow-up	We will gather practice-specific rates of coverage for adolescents (age 11-12) for tetanus, diphtheria, and pertussis booster (Tdap) at baseline and 5 months follow-up.
Change in Vaccination Rate: Tdap vaccine among 13-18 year olds	Baseline and 5 months follow-up	We will gather practice-specific rates of coverage for adolescents (age 13-18) for tetanus, diphtheria, and pertussis booster (Tdap) at baseline and 5 months follow-up.
Change in Vaccination Rate: Meningitis vaccine among 11-12 year olds	Baseline and 5 months follow-up	We will gather practice-specific rates of coverage for adolescents (age 11-12) for meningococcal conjugate (i.e., meningitis vaccine) at baseline and 5 months follow-up.
Change in Vaccination Rate: Meningitis vaccine among 13-18 year olds	Baseline and 5 months follow-up	We will gather practice-specific rates of coverage for adolescents (age 13-18) for meningococcal conjugate (i.e., meningitis vaccine) at baseline and 5 months follow-up.
Change in Vaccination Rate: HPV vaccine completion among 11-12 year olds	Baseline and 5 months follow-up	We will gather practice-specific rates of coverage for adolescents (age 11-12) for the third and final dose of human papillomavirus (HPV) vaccine at baseline and 5 months follow-up.
Change in Vaccination Rate: HPV vaccine completion among 13-18 year olds	Baseline and 5 months follow-up	We will gather practice-specific rates of coverage for adolescents (age 13-18) for the third and final dose of human papillomavirus (HPV) vaccine at baseline and 5 months follow-up.

Trial Locations

Locations (2)

North Carolina Immunization Branch; 🇺🇸 Raleigh, North Carolina, United States

Cervical Cancer-Free North Carolina; 🇺🇸 Chapel Hill, North Carolina, United States